Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Authors

Institutions

Publication Details

Journal
Asia Pacific Allergy
Published
2024-08-05
DOI
https://doi.org/10.5415/apallergy.0000000000000156
Citations
10
Primary Topic
Sinusitis and nasal conditions
Type
article
Field-Weighted Citation Impact
5.80
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Bing Yan, Chengshuo Wang, Luo Zhang, Ming Wang et al.
10 citations
Asia Pacific Allergy
Sinusitis and nasal conditions
5.80
article

Anti-IL-4Rα monoclonal antibody (CM310) in patients with chronic rhinosinusitis with nasal polyps (CROWNS-2): Rationale and design of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study

Bing Yan, Chengshuo Wang, Luo Zhang, Ming Wang, Shen Shen, Di Wu
article en
10 citations

Abstract

No abstract available for this paper.
Asia Pacific AllergyVol. 14(3)
Beijing Tongren Hospital (CN), Capital Medical University (CN), Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Openalex Percentile: Top 3%
Sinusitis and nasal conditions
5.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.